These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7314329)

  • 1. Effects of a cation exchange resin on intestinal calcium absorption and urinary calcium in calcium stone formers.
    Scholz D; Schwille PO; Herzog T; Sigel A
    Urol Res; 1981; 9(6):263-9. PubMed ID: 7314329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cation exchange resin and calcium excretion. An experimental study.
    Lurie A; Kursh ED; Rose D; Persky L
    Invest Urol; 1976 Jan; 13(4):307-8. PubMed ID: 1245394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term clinical experiences with the cation exchanger UJOLYT as a metaphylactic in absorptive hypercalciuria and chronic recurring calcium oxalate lithiasis].
    Böhm WD
    Z Urol Nephrol; 1983 Jul; 76(7):445-51. PubMed ID: 6637172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cation exchange resin preparation in recurrent calcium urolithiasis.
    Rugendorff EW; Schneider HJ
    Urology; 1983 Aug; 22(2):143-50. PubMed ID: 6879885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cellulose phosphate on intestinal absorption and urinary excretion of calcium. Some experience in its use in the treatment of calcium stone formation.
    Blacklock NJ; Macleod MA
    Br J Urol; 1974 Aug; 46(4):385-92. PubMed ID: 4416182
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of cation exchange resin to impair intestinal absorption of terramycin.
    GRONROOS JA; KALLIOMAKI L
    Scand J Clin Lab Invest; 1953; 5(4):378-9. PubMed ID: 13146041
    [No Abstract]   [Full Text] [Related]  

  • 7. [A study of calcium metabolism in calcium-containing stone formers].
    Ikeda M; Ohmori A
    Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1313-21. PubMed ID: 7474614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of clinical trials with the cation exchange preparation campanyl in the therapy and metaphylaxis of calcium-containing urinary calculi (author's transl)].
    Rugendorff EW; Schneider HJ; Gundlach G; Behrendt WA; Kuhn D; Gundlach D
    Urologe A; 1977 Jul; 16(4):197-203. PubMed ID: 331626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of an orally administered calcium-binding cation exchanger on calcium metabolism in the rat.
    Hagmaier V; Flückiger B; Scholer A; Remagen W; Rutishauser G
    Urol Res; 1979 Dec; 7(4):277-9. PubMed ID: 524565
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Report on a symposium on the treatment of Ca-containing urinary calculi using ion exchangers, Munich, May 8, 1976].
    Schmiedt E
    Urologe A; 1976 Sep; 15(5):262. PubMed ID: 973283
    [No Abstract]   [Full Text] [Related]  

  • 12. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium cellulose phosphate (Calcibind).
    Med Lett Drugs Ther; 1983 Jul; 25(639):67-8. PubMed ID: 6865849
    [No Abstract]   [Full Text] [Related]  

  • 14. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cation-exchange resin and inhibition of intestinal absorption of thyroxine.
    McLean M; Kirkwood I; Epstein M; Jones B; Hall C
    Lancet; 1993 May; 341(8855):1286. PubMed ID: 8098431
    [No Abstract]   [Full Text] [Related]  

  • 16. [Citrate as an inhibitor of stone formation--with reference to intestinal citrate absorption and the influence of citrate on intestinal calcium absorption].
    Yasukawa S; Uehara M; Yamauchi T; Morimoto S; Ebisuno S; Ohkawa T
    Hinyokika Kiyo; 1991 Oct; 37(10):1103-6. PubMed ID: 1755398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Enteral' hyperoxaluria. Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man.
    Caspary WF; Tönissen J; Lankisch PG
    Acta Hepatogastroenterol (Stuttg); 1977 Jun; 24(3):193-200. PubMed ID: 883468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E; Schmidt-Gayk H; Möhring K
    Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the fractional isotopic calcium absorption and an oral calcium tolerance test.
    Bergmann P; Fuss M
    Calcif Tissue Int; 1983 Sep; 35(6):819-20. PubMed ID: 6652557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary calcium and phosphorus excretion and their relationship in calcium-containing urinary stone formers].
    Kitamura T; Moriyama N; Kawabe K; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Feb; 80(2):197-203. PubMed ID: 2747084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.